References
- Miller, H., D. J. Newell, and A. Ridley. 1961. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.). Lancet. 2: 1120–1122
- Rose, A. S., J. W. Kuzma, J. F. Kurtzke, et al. 1970. Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo – final report. Neurology 20: 1–59
- Thompson, A. J., C. Kennard, M. Swash, B. Summers, et al. 1989. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 39: 969–971
- Catania, A., S. Gatti, G. Colombo, and J. M. Lipton. 2004. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56: 1–29
- Arnason, B. G., R. Berkovich, A. Catania, et al. 2013. Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult. Scler. 19: 130–136
- Libbey, J. E., I. Tsunoda, and R. S. Fujinami. 2010. Studies in the modulation of experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5: 168–175
- Tsunoda, I., and R. S. Fujinami. 1996. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler’s murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55: 673–686
- Libbey, J. E., and R. S. Fujinami. 2011. Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine 29: 3356–3362
- Steinman, L., and S. S. Zamvil. 2006. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60: 12–21
- Field, E. J., and H. Miller. 1961. Studies in the inhibition of experimental allergic encephalomyelitis. Arch. Int. Pharmacodyn. Ther. 134: 76–88
- Moyer, A. W., G. A. Jervis, J. Black, et al. 1950. Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig. Proc. Soc. Exp. Biol. Med. 75: 387–390
- Brod, S. A., and Z. M. Hood. 2011. Ingested (oral) ACTH inhibits EAE. J. Neuroimmunol. 232: 131–135
- Brod, S. A., and Z. M. Hood. 2008. Ingested (oral) alpha-MSH inhibits acute EAE. J. Neuroimmunol. 193: 106–112
- Tuohy, V. K., Z. Lu, R. A. Sobel, et al. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523–1527
- Ahmed, R. 1992. Immunological memory against viruses. Semin. Immunol. 4: 105–109
- Cusick, M. F., J. E. Libbey, N. S. Trede, et al. 2012. Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen. J. Neuroimmunol. 244: 35–44
- Decker, D., C. Grant, L. Oh, et al. 2014. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus. Lupus 23: 802–812
- Kirkman, N. J., J. E. Libbey, K. S. Wilcox, et al. 2010. Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 51: 454–464
- Trede, N. S., W. Heaton, S. Ridges, et al. 2013. Discovery of biologically active oncologic and immunologic small molecule therapies using zebrafish: overview and example of modulation of T cell activation. Curr. Protoc. Pharmacol. Chapter 14, Unit14.24
- Nair, A., T. J. Frederick, and S. D. Miller. 2008. Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65: 2702–2720
- Eng, L. F. 1985. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8: 203–214
- Cusick, M. F., J. E. Libbey, D. C. Patel, et al. 2013. Infiltrating macrophages are key to the development of seizures following virus infection. J. Virol. 87: 1849–1860
- Delgado, R., A. Carlin, L. Airaghi, et al. 1998. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63: 740–745
- Taylor, A. W., and K. Namba. 2001. In vitro induction of CD25+CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell. Biol. 79: 358–367
- Besser, G. M., P. W. Butler, and F. S. Plumpton. 1967. Adrenocorticotrophic action of long – acting tretracosactrin compared with corticotrophin-gel. Br. Med. J. 4: 391–394
- Coburg, A. J., S. H. Gray, F. H. Katz, et al. 1970. Disappearing rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg. Gynecol. Obstet. 131: 933–942
- Taylor, A. W., and N. Kitaichi. 2008. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav. Immun. 22: 639–646
- Beers, D. R., J. S. Henkel, Q. Xiao, et al. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103: 16021–16026
- Ginhoux, F., M. Greter, M. Leboeuf, et al. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841–845
- McKercher, S. R., B. E. Torbett, K. L. Anderson, et al. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647–5658
- Ponomarev, E. D., L. P. Shriver, K. Maresz, and B. N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81: 374–389
- Ford, A. L., A. L. Goodsall, W. F. Hickey, and J. D. Sedgwick. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154: 4309–4321
- Sedgwick, J. D., S. Schwender, H. Imrich, et al. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 88: 7438–7442